NLRP12.com's blog with news, updates and comments on all things rare and autoinflammatory

  • Home
  • To NLRP12.com web site

Pharma

Funding Restrictions

Humane Resources: Funding Restrictions in Rare Rheumatic Diseases

June 20, 2017 John 0

As any rheumatologist knows, most non-medical individuals don’t really know what ‘rheumatology’ is.  Not so much of a bad reputation, as no reputation.  Relatives and […]

Patient Engagement

Rare Disease Clinical Development: The Crucial Need for Patient and Parent Involvement

June 20, 2017 John 0

LuAnn Sabounjian, Head of Clinical Operations & Drug Safety, PROMETRIKA, LLC Rare Disease Clinical Trials February 28th, 2017 was the tenth observance of Rare Disease […]

Global Genes Connect Collaborate Advance

Global Genes® to Convene RARE Partnering and Investor Forum to Accelerate Drug Development for Rare Diseases

May 23, 2017 John 0

[Aliso Viejo, CA] May 19, 2017 – Global Genes®, a leading rare disease patient advocacy organization, will host the inaugural RARE Partnering and Investor Forum, […]

NHS Scotland

Three new medicines cleared for use by NHS Scotland

May 11, 2017 John 0

The Scottish Medicines Consortium has endorsed three medicines for routine use by NHS Scotland, offering new options to treat a rare eye disease, lupus and […]

A Nuanced Message: Marketing to the Rare Diseases Community

May 10, 2017 John 0

Check traditional marketing strategies at the door, because when it comes to rare diseases they simply don’t apply. Experts say established methods of directing campaigns […]

Pharma Prices

Big Pharma Losing Leverage as Payers Raise Pressure on Price

May 7, 2017 John 0

Consolidation among insurers, pharmacy benefit managers key Drug companies are citing growth by volume instead of price Byline: Jared S. Hopkins and Doni Bloomfield, Bloomberg […]

Navigation

  • Home
  • To NLRP12.com web site
  • FCAS2
  • NLRP12
  • Ultra Rare
  • Autoinflammatory
  • Drugs
    • Orphan Drugs
  • Pharma
  • Genetics
  • Autoimmune
  • Software
  • Rare Disease
  • Ultra Rare
  • UK
    • Scotland
      • NHS Scotland
    • Northern Ireland
    • Wales
    • England
  • USA
  • Campaigning
  • Uncategorized

What advice would you give to others?

  • Humane Resources: Funding Restrictions in Rare Rheumatic Diseases
  • Rare Disease Clinical Development: The Crucial Need for Patient and Parent Involvement
  • Living with a rare disease: a husband and father’s perspective
  • Global Genes® to Convene RARE Partnering and Investor Forum to Accelerate Drug Development for Rare Diseases
  • Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.
  • We must act as England falls behind on access to rare disease medicines
  • App-based tool for clinicians using facial recognition, AI and genetic big data to improve rare disease diagnosis and treatment
  • Three new medicines cleared for use by NHS Scotland
  • NORD Launches Free CME Program to Educate Medical Professionals about Rare Diseases
  • A Nuanced Message: Marketing to the Rare Diseases Community
Advocacy Australian Autoimmune Autoinflammatory Campaigning Child Drug Costs England Genetics Hereditory Immune System India LHON Lifestyle Marketing NHS Scotland Pharma Rare Disease Rare Disease Marketing Rare Disease Registry SLE SMC UK ultra-rare USA
No comments found

Archives

| Privacy Policy | Terms & Conditions |
| Cookie Policy | Disclaimer |
Nothing on this blog is medical advice. This blog is for INFORMATION only.
If you need medical advice, please call a medical professional.

Copyright © 2023 | WordPress Theme by MH Themes